[1]
Bushuieva, I.V. , Petrova, K.V., Kyrychko, B.P. and Parchenko, V.V. 2022. Study of mutagenic effects with predicted carcinogenicity of 4-((5-decylthio)-4-methyl-4-H-1,2,4-triazole-3-yl)methyl)morpholine for further research in order to create a new drug with antifungal activity. Current issues in pharmacy and medicine: science and practice. 15, 3 (Nov. 2022), 271–276. DOI:https://doi.org/10.14739/2409-2932.2022.3.261790.